Inclusion Criteria:  The subject is undergoing endovascular intervention for the management of their PAD. The subject is between 40 to 90 years of age. Documented lower limb arterial occlusive or stenotic disease (using ankle-brachial index / pulse volume recording, duplex ultrasound or CT angiogram) within the last 8 weeks. In the opinion of the Investigator, the subject is willing and able to comply with the protocol and complete all protocol assessments. The subject has been informed of the nature of the study, agrees to its provisions and has willingly provided written informed consent, approved by the appropriate Institutional Review Board (IRB)  Exclusion Criteria:  Subjects on an investigational drug or being treated with an investigational therapeutic device, within 30 days of the study visit, that in the view of the Investigator might interfere with the study outcomes. Presence of a condition that the Investigator considers will compromise the subject's ability to participate in the study. Subjects on renal replacement therapy Signs of active infection causing localized inflammation on the plantar or dorsal surfaces of the foot. Lack of intact skin, or pathological skin conditions, at the proposed sensor pad positions that may impair or prevent the adherence of medical adhesives in general. Diabetic subjects with a Charcot neuropathic osteoarthropathy